Drugs / Granulocyte-colony stimulating growth factor
Granulocyte-colony stimulating growth factor
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT01985724 Background | Oct 2007 → Dec 2013 | breast cancer | Hellenic Oncology Research Group | Completed | Missed primary |
| Phase 3 | NCT00615602 Background | Oct 2004 → May 2012 | female breast carcinoma | Hellenic Oncology Research Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Granulocyte-colony stimulating growth factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00615602 ↗ |
| Modality | Protein / enzyme biologic | “rhG-CSF 5 μg/kg/d on days 3-10 after each cycle” NCT01985724 ↗ |